• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名23岁酪氨酸血症患者的肝移植:对肾小管功能障碍的影响

Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

作者信息

Kvittingen E A, Jellum E, Stokke O, Flatmark A, Bergan A, Sødal G, Halvorsen S, Schrumpf E, Gjone E

出版信息

J Inherit Metab Dis. 1986;9(2):216-24. doi: 10.1007/BF01799465.

DOI:10.1007/BF01799465
PMID:3091928
Abstract

Orthotopic liver transplantation was performed on a 23-year-old female with hereditary tyrosinaemia. The disorder was diagnosed at 7 years of age due to severe rickets, and the patient was treated with a diet restricted in phenylalanine and tyrosine. Nineteen months before the transplantation she had an acute episode of diffuse gastrointestinal bleeding due to portal hypertension. Three subsequent bleeding episodes with accompanying ascites and signs of encephalopathy were considered life-threatening. Nine months after the liver transplantation the patient is well, but serum transaminases are slightly elevated. Without dietary restrictions serum tyrosine and inorganic phosphate are normalized, no succinylacetone can be detected in serum, and urinary excretion of p-hydroxyphenyllactate and p-hydroxyphenylpyruvate is normal. Excretion of amino acids, glucose and beta 2-microglobulin decreased significantly after the transplantation but is still elevated. The succinylacetone concentration in urine is about 20% of the preoperative level. After an oral tyrosine load, succinylacetone excretion increased sevenfold but no deterioration of the renal tubular function was observed and no tyrosine metabolites were detectable in serum. The findings indicate that the defective tyrosine metabolism occurs in the kidneys, but does not produce tubular dysfunction. The residual tubular dysfunction of the patient is probably due to irreversible damage of the tubular epithelium.

摘要

对一名患有遗传性酪氨酸血症的23岁女性进行了原位肝移植。该疾病在患者7岁时因严重佝偻病被诊断出来,患者接受了限制苯丙氨酸和酪氨酸的饮食治疗。在移植前19个月,她因门静脉高压出现了一次急性弥漫性胃肠道出血。随后又发生了三次出血事件,并伴有腹水和脑病迹象,被认为危及生命。肝移植九个月后,患者情况良好,但血清转氨酶略有升高。在没有饮食限制的情况下,血清酪氨酸和无机磷酸盐恢复正常,血清中未检测到琥珀酰丙酮,对羟基苯乳酸和对羟基苯丙酮酸的尿排泄正常。移植后氨基酸、葡萄糖和β2-微球蛋白的排泄显著减少,但仍高于正常水平。尿中琥珀酰丙酮浓度约为术前水平的20%。口服酪氨酸负荷后,琥珀酰丙酮排泄增加了七倍,但未观察到肾小管功能恶化,血清中也未检测到酪氨酸代谢产物。这些发现表明,酪氨酸代谢缺陷发生在肾脏,但不会导致肾小管功能障碍。患者残留的肾小管功能障碍可能是由于肾小管上皮的不可逆损伤。

相似文献

1
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.一名23岁酪氨酸血症患者的肝移植:对肾小管功能障碍的影响
J Inherit Metab Dis. 1986;9(2):216-24. doi: 10.1007/BF01799465.
2
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.通过抑制4-羟基苯丙酮酸双加氧酶治疗I型遗传性酪氨酸血症。
Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9.
3
Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.肝移植后I型酪氨酸血症患者的肾功能:长期随访
J Inherit Metab Dis. 2005;28(6):871-6. doi: 10.1007/s10545-005-0059-0.
4
Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.饮食治疗对一名遗传性酪氨酸血症患者肾小管功能的影响。
Int J Pediatr Nephrol. 1987 Jul-Sep;8(3):171-6.
5
Renal failure in adult patients with hereditary tyrosinaemia type I.成年I型遗传性酪氨酸血症患者的肾衰竭
J Inherit Metab Dis. 1991;14(1):53-62. doi: 10.1007/BF01804389.
6
Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.饮食治疗可消除1型酪氨酸血症患者尿液中的琥珀酰丙酮。
Eur J Pediatr. 1990 Jun;149(9):637-9. doi: 10.1007/BF02034752.
7
Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.肝移植后与酪氨酸血症相关的肾小管功能障碍迅速改善。
Pediatrics. 1992 Feb;89(2):251-5.
8
On the renal tubular damage in hereditary tyrosinemia and on the formation of succinylacetoacetate and succinylacetone.关于遗传性酪氨酸血症中的肾小管损伤以及琥珀酰乙酰乙酸和琥珀酰丙酮的形成
Acta Paediatr Scand. 1981;70(3):315-20. doi: 10.1111/j.1651-2227.1981.tb16558.x.
9
Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.一名I型遗传性酪氨酸血症患者肝移植后持续排泄琥珀酰丙酮。
J Inherit Metab Dis. 1985;8(1):21-4. doi: 10.1007/BF01805479.
10
Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.无佝偻病及肾小管功能障碍的慢性病程遗传性酪氨酸血症
Acta Paediatr Scand. 1990 Nov;79(11):1063-8. doi: 10.1111/j.1651-2227.1990.tb11384.x.

引用本文的文献

1
Renal tubular function in children with tyrosinaemia type I treated with nitisinone.用尼替西农治疗的Ⅰ型酪氨酸血症患儿的肾小管功能
J Inherit Metab Dis. 2008 Jun;31(3):399-402. doi: 10.1007/s10545-008-0817-x. Epub 2008 May 23.
2
Current strategies for the treatment of hereditary tyrosinemia type I.目前治疗I型遗传性酪氨酸血症的策略。
Paediatr Drugs. 2006;8(1):47-54. doi: 10.2165/00148581-200608010-00004.
3
Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.肝移植后I型酪氨酸血症患者的肾功能:长期随访

本文引用的文献

1
Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.遗传性酪氨酸血症患者淋巴细胞和成纤维细胞中富马酰乙酰乙酸富马酰水解酶活性缺乏。
Pediatr Res. 1983 Jul;17(7):541-4. doi: 10.1203/00006450-198307000-00005.
2
Dietary treatment of tyrosinosis.酪氨酸血症的饮食治疗。
Am J Dis Child. 1967 Jan;113(1):38-40. doi: 10.1001/archpedi.1967.02090160088007.
3
Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.
J Inherit Metab Dis. 2005;28(6):871-6. doi: 10.1007/s10545-005-0059-0.
4
Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.尽管患有I型慢性酪氨酸血症,但仍长期存活的肝细胞癌。
J Inherit Metab Dis. 2000 Dec;23(8):791-804. doi: 10.1023/a:1026756501669.
5
Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.I型遗传性酪氨酸血症小鼠模型的治疗试验:进展报告。
J Inherit Metab Dis. 1998 Aug;21(5):518-31. doi: 10.1023/a:1005462804271.
6
Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.两个错义突变导致1型酪氨酸血症,伴有或不伴有免疫反应性延胡索酰乙酰乙酸酶。
Hum Genet. 1994 Jun;93(6):615-9. doi: 10.1007/BF00201558.
7
Visceral pathology of hereditary tyrosinemia type I.I型遗传性酪氨酸血症的内脏病理学
Am J Hum Genet. 1990 Aug;47(2):317-24.
8
Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.饮食治疗可消除1型酪氨酸血症患者尿液中的琥珀酰丙酮。
Eur J Pediatr. 1990 Jun;149(9):637-9. doi: 10.1007/BF02034752.
9
Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh.酪氨酸血症的肝移植。匹兹堡大学10例病例回顾。
Dig Dis Sci. 1990 Jan;35(1):153-7. doi: 10.1007/BF01537237.
10
Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15.编码人富马酰乙酰乙酸水解酶(遗传性酪氨酸血症中缺乏的酶)的cDNA的克隆与表达:该基因定位于15号染色体
Am J Hum Genet. 1991 Mar;48(3):525-35.
酪氨酸血症(酪氨酸病)的饮食治疗。关于携带者状态可能识别的说明。
Am J Dis Child. 1967 Jan;113(1):31-7. doi: 10.1001/archpedi.1967.02090160081006.
4
Maleic acid-induced inhibition of amino acid transport in rat kidney.马来酸诱导的大鼠肾脏氨基酸转运抑制
Biochem J. 1964 Aug;92(2):345-52. doi: 10.1042/bj0920345.
5
Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.采用气液色谱法对遗传性酪氨酸血症中酚酸代谢的研究。
J Lab Clin Med. 1969 Aug;74(2):185-202.
6
A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes.一项关于人红细胞溶血产物中5-氨基乙酰丙酸水解酶(δ-氨基乙酰丙酸脱水酶)活性测定的研究。
Clin Biochem. 1971 Dec;4(4):222-32. doi: 10.1016/s0009-9120(71)91692-4.
7
Assay, properties and tissue distribution of p-hydroxyphenylpyruvate hydroxylase.对羟基苯丙酮酸羟化酶的测定、性质及组织分布
Biochim Biophys Acta. 1972 Sep 19;284(1):90-100. doi: 10.1016/0005-2744(72)90048-4.
8
Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans.人类原位肝同种移植术后血清触珠蛋白和类属特异性成分的变化。
Proc Soc Exp Biol Med. 1968 May;128(1):247-50. doi: 10.3181/00379727-128-32988.
9
Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.观念的转变:肝移植治疗遗传性酪氨酸血症和肝癌。
J Pediatr. 1985 Apr;106(4):604-6. doi: 10.1016/s0022-3476(85)80081-0.
10
Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.一名I型遗传性酪氨酸血症患者肝移植后持续排泄琥珀酰丙酮。
J Inherit Metab Dis. 1985;8(1):21-4. doi: 10.1007/BF01805479.